Research theme for competitive and other funds (1)：
2023 - 2026 Evaluation of sarcopenic dysphagia in perioperative period of gastric cancer and prevention of pneumonia by rehabilitation
Papers (239)：
Yurina Saito, Tsuyoshi Takahashi, Toshirou Nishida, Kohei Murakami, Shunji Endo, Kazuhiro Nishikawa, Yutaka Kimura, Masaaki Motoori, Koji Tanaka, Yasuhiro Miyazaki, et al. Long-Term Outcomes of Pylorus-Preserving Gastrectomy for Early Gastric Cancer. The American SurgeonTM. 2023. 90. 3. 386-392
Kazuhiro Nishikawa, Hisato Kawakami, Toshio Shimokawa, Kazumasa Fujitani, Shigeyuki Tamura, Shunji Endo, Michiya Kobayashi, Junji Kawada, Yukinori Kurokawa, Akira Tsuburaya, et al. Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer. International journal of clinical oncology. 2023
Hisato Kawakami, Kazuhiro Nishikawa, Toshio Shimokawa, Kazumasa Fujitani, Shigeyuki Tamura, Shunji Endo, Michiya Kobayashi, Junji Kawada, Yukinori Kurokawa, Akira Tsuburaya, et al. Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease. Cancers. 2022. 14. 22
Shunji Endo, Tetsuji Terazawa, Masahiro Goto, Ryo Tanaka, Takeshi Kato, Kazumasa Fujitani, Hisato Kawakami, Daisuke Sakai, Yukinori Kurokawa, Toshimasa Tsujinaka, et al. Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study. BMC cancer. 2022. 22. 1. 811-811
